Search Within

Alexander Noor Shoushtari

Formats
  1. Journal Article (114)
  2. Meeting Abstract (106)
  3. Research Letter (11)
  4. Editorial (7)
  5. Review (4)
  6. Book Section (3)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (247)
  2. Hematologic Malignancies, Division of (247)
  3. Melanoma Disease Management Team (247)
  4. Melanoma and Immunotherapeutics Service (247)
  5. Solid Tumor Oncology Division (247)
  6. GSK Faculty (87)

More Groups

People
  1. Michael Postow (64)
  2. Jedd Wolchok (49)
  3. Margaret Callahan (46)
  4. Paul Chapman (46)
  5. Katherine Panageas (35)
  6. Parisa Momtaz (33)

More People

Years
  1. 2025 (7)
  2. 2024 (22)
  3. 2023 (25)
  4. 2022 (38)
  5. 2021 (38)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (67)
  2. Annals of Oncology (22)
  3. Journal for ImmunoTherapy of Cancer (17)
  4. Clinical Cancer Research (11)
  5. Cancer Research (7)
  6. Melanoma Research (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (70)
  2. Oxford University Press (29)
  3. American Association for Cancer Research (21)
  4. Biomed Central Ltd (21)
  5. Nature Publishing Group (15)
  6. Elsevier Inc. (13)

More Publishers

Results (247)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intracranial outcomes with ipilimumab and nivolumab in melanoma brain metastases following progression on anti-PD-1 therapy
    Meeting Abstract

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Germline pathogenic variants in a large convenience cohort of multiple melanoma subtypes
    Meeting Abstract

    Lochrin, S. E.; Kemel, Y.; Stuart, J.; Smithy, J. W.; Mandelker, D.; Momtaz, P.; Chatila, W. K.; Schultz, N.; Postow, M. A.; Stadler, Z. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Conjunctival melanoma and cell-free DNA regression with ipilimumab/nivolumab and stereotactic radiosurgery
    Miscellaneous

    Francis, J. H.; Barker, C.; Koenig, L. R.; Della Rocca, D.; Shoushtari, A.
    Ophthalmic Plastic and Reconstructive Surgery (2024)

    Fulltext@MSK | Save
  • A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Journal Article

    Barker, C. A.; D'Angelo, S. P.; Wasilewski, G.; Steckler, A. M.; Lian, M.; Zhang, Z.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Early on-treatment assessment of T cells, cytokines, and tumor DNA with adaptively dosed nivolumab + ipilimumab: Final results from the phase 2 ADAPT-IT study
    Journal Article

    Smithy, J. W.; Kalvin, H. L.; Ehrich, F. D.; Shah, R.; Adamow, M.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
    Journal Article

    Sacco, J. J.; Carvajal, R. D.; Butler, M. O.; Shoushtari, A. N.; Hassel, J. C.; Ikeguchi, A.; Hernandez-Aya, L.; Nathan, P.; Hamid, O.; Piulats, J. M.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: A propensity score-weighted analysis
    Journal Article

    Piulats, J. M.; Watkins, C.; Costa-García, M.; del Carpio, L.; Piperno-Neumann, S.; Rutkowski, P.; Hassel, J. C.; Espinosa, E.; de la Cruz-Merino, L.; Ochsenreither, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Clearance of plasma cell free DNA in metastatic uveal melanoma with radiographic response to immune checkpoint inhibitors
    Journal Article

    Francis, J. H.; Barker, C. A.; Canestraro, J.; Abramson, D. H.; Shoushtari, A. N.
    American Journal of Ophthalmology Case Reports (2024)

    Fulltext@MSK | Save
  • The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
    Journal Article

    Hepner, A.; Versluis, J. M.; Wallace, R.; Allayous, C.; Brown, L. J.; Trojaniello, C.; Gerard, C. L.; Jansen, Y. J. L.; Bhave, P.; Neyns, B.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Three-year overall survival with tebentafusp in metastatic uveal melanoma
    Journal Article

    Hassel, J. C.; Piperno-Neumann, S.; Rutkowski, P.; Baurain, J. F.; Schlaak, M.; Butler, M. O.; Sullivan, R. J.; Dummer, R.; Kirkwood, J. M.; Orloff, M.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save